Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioNexus Gene Lab
Wyoming, USAbionexusgenelab.com ↗
- Ownership
- Public · BGLC
- Employees
- ~30
- Development stage
- Other
01
Overview
BioNexus Gene Lab has developed and commercialized a proprietary blood-based genomic screening test that analyzes changes in circulating RNA to predict predisposition to certain cancers, inflammatory diseases, and osteoarthritis. The technology enables non-invasive early detection before symptoms appear. The company also supplies specialty chemical raw materials through its Chemrex subsidiary.
- Therapeutic areas
- OncologyImmunologyRheumatology
- Modalities
- RNA-based diagnostics (liquid biopsy)Molecular diagnostic assay
- Industry
- Molecular Diagnostics
02
Financials
- Market cap
- $2.1M
- Total revenue
- $7.4M
- Enterprise value
- $-1.3M
Beyond the preview
Go deeper on BioNexus Gene Lab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioNexus Gene Lab.